Business Information
The group’s principal activity is to provide products and services supporting the healthcare industry. The group operates through four segments namely, pharmaceutical services, medical products and services, pharmaceutical technologies and services, and clinical technologies and services. In the year 2006, the group acquired PerMed Pharmaceutical, Inc. The group’s specific customers are CVS Corporation and Walgreen Co. The group operates from the United States. Of the total revenue in the year 2006, the pharmaceutical services segment accounted for $67,100.7, medical products and services $10,013.8, pharmaceutical technologies and services $2,826.4, and clinical technologies and services $2,430.3 (millions).
|
|
Name |
Title
|
Email
|
| Kerry Clark | Chmn., CEO | N/A | | Dave Schlotterbeck | CEO - Clinical, Medical Products | N/A | | Dwight Winstead | Group Pres. - Clinical Technologies, Services | N/A | | Frank Segrave | Pres. - Generics | N/A | | Mark Parrish | CEO - Healthcare Supply Chain Services | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 81,363,600 | 1,000,100 | | 2005 | 74,910,700 | 1,050,700 | | 2004 | 65,053,500 | 1,474,500
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
